Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Cell Surface Markers Market By Instrument and Reagent Type, Application and End User and Region Forecast 2019-2030
Cell Surface Markers Market By Instrument and Reagent Type, Application and End User and Region Forecast 2019-2030
Cell Surface Markers Market size was valued at US$ 689 million in 2023 and is poised to grow at a significant CAGR of 8.2% from 2024-2030. Bladder diseases is an umbrella term used to depict neurotic conditions that influence the structure or capacity of the bladder. Bladder ailments incorporate conditions identified with irritation, disease and urinary incontinence. This market is a remote therapeutic gadget that utilizations high-recurrence sound waves to produce a picture of the bladder of the individual. The major drivers of the global market includes expansion of human services innovation and decrease the cost of ailment determination.
The expansion in frequency of tumor and other immune system sickness fortifying the interest for the improvement of disentanglement of infections recognizable proof and the rising mechanization of arrangements and advancements are anticipated to fuel the market. Additionally, expanded research for the use of undeveloped cell innovation is profiting the part to develop. Nonetheless, the central point which are limiting cell surface markers identification developments are intricate items and costly instruments and reagents utilized as a part of cell marker investigation. The market is expected to gain huge traction due to advancements in fluorescence innovation, improvements of cytometric procedures. Presentation of fluorescence-enacted cell arranging (FACS) calculations for fast and quantitative examination of cells is foreseen to fuel industry development in future. Companies are focused on joint ventures with different players in the business to enhance market presence.
Study Period
2024-2030Base Year
2023CAGR
8.2%Largest Market
North AmericaFastest Growing Market
Asia-Pacific
The market's growth is projected to be hampered by a lack of willingness to invest heavily in advanced models. Many clinical laboratories are hesitant to invest in sophisticated cell marker analysis tools due to the complexity and high cost of instruments, as well as the uncertainty surrounding the regulation and reimbursement of cell marker diagnostic procedures. The size and nature of the diagnostic facility also influence the need for such instruments. Outsourcing of such jobs to larger clinical laboratories is a result of economic concerns about operational sustainability in medium and small clinical laboratories and hospitals.
Geographically Cell Surface Markers Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America leads the worldwide market followed by Europe. North America rules the market due the nearness of significant key players and ceaseless complex R&D innovation advancement in the locale. Social insurance foundation change and developing inclination for simpler and more secure focused on treatments are the main considerations which powers the market development in these areas. Also, the expanding frequency rate of tumor and other incessant infection prompt request of demonstrative request enlarging for the North America market. APAC is relied upon to witness critical development when contrasted with different locales and nations inferable from expanded medicinal services and research use. Additionally, the quick increment in geriatric populace base moving local industry development.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 689 million |
|
Market CAGR |
8.2% |
|
By Reagent Type |
|
|
By Application |
|
|
By End-User |
|
|
By Region |
|
Download Free Sample Report
The global cell surface markers market size is valued at US$ 689 million in 2023 and is set to surpass at a robust CAGR of 8.2% from 2024-2030.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
Beckman Coulter, Inc., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Merck&Co., Inc., Luminex Corporation, Sysmex Partec GmbH, Bio-Rad Laboratories, Inc., Miltenyi Biotec GmbH, Sony Biotechnology
The Cell Surface Markers Market faces threats such as increasing competition, regulatory challenges, and potential limitations in technology advancements.
| 1.Executive Summary |
| 2.Global Cell Surface Markers Market Introduction |
| 2.1.Global Cell Surface Markers Market - Taxonomy |
| 2.2.Global Cell Surface Markers Market - Definitions |
| 2.2.1.Reagent Type |
| 2.2.2.Application |
| 2.2.3.End-User |
| 2.2.4.Region |
| 3.Global Cell Surface Markers Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Cell Surface Markers Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Cell Surface Markers Market By Reagent Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Flow Cytometer |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Hematology Analyzers |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Reagents and Kits |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Cell Surface Markers Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Disease Diagnosis |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Research and Drug Discovery |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 7.Global Cell Surface Markers Market By End-User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Homecare |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Ambulatory Care Centers |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Cell Surface Markers Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Cell Surface Markers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Reagent Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Flow Cytometer |
| 9.1.2.Hematology Analyzers |
| 9.1.3.Reagents and Kits |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Disease Diagnosis |
| 9.2.2.Research and Drug Discovery |
| 9.3. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Homecare |
| 9.3.3.Ambulatory Care Centers |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Cell Surface Markers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Reagent Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Flow Cytometer |
| 10.1.2.Hematology Analyzers |
| 10.1.3.Reagents and Kits |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Disease Diagnosis |
| 10.2.2.Research and Drug Discovery |
| 10.3. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Homecare |
| 10.3.3.Ambulatory Care Centers |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 10.4.6.Rest of EU |
| 11.Asia Pacific (APAC) Cell Surface Markers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Reagent Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Flow Cytometer |
| 11.1.2.Hematology Analyzers |
| 11.1.3.Reagents and Kits |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Disease Diagnosis |
| 11.2.2.Research and Drug Discovery |
| 11.3. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Homecare |
| 11.3.3.Ambulatory Care Centers |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Cell Surface Markers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Reagent Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Flow Cytometer |
| 12.1.2.Hematology Analyzers |
| 12.1.3.Reagents and Kits |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Disease Diagnosis |
| 12.2.2.Research and Drug Discovery |
| 12.3. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Homecare |
| 12.3.3.Ambulatory Care Centers |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Cell Surface Markers Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Reagent Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Flow Cytometer |
| 13.1.2.Hematology Analyzers |
| 13.1.3.Reagents and Kits |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Disease Diagnosis |
| 13.2.2.Research and Drug Discovery |
| 13.3. End-User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Homecare |
| 13.3.3.Ambulatory Care Centers |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Beckman Coulter, Inc. (U.S.) |
| 14.2.2.Becton, Dickinson and Company (U.S.) |
| 14.2.3.Thermo Fisher Scientific, Inc. (U.S.) |
| 14.2.4.Merck&Co., Inc. (US) |
| 14.2.5.Luminex Corporation (U.S.) |
| 14.2.6.Sysmex Partec GmbH (Germany) |
| 14.2.8.Miltenyi Biotec GmbH (Germany) |
| 14.2.9.Sony Biotechnology (U.S.) |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.